Literature DB >> 32269684

miR-103 promotes hepatocellular carcinoma cell proliferation and migration in the simulation transition zone of RFA through PI3K/Akt signaling pathway by targeting PTEN.

Yunhua Tan1, Liang Zhao2.   

Abstract

Radiofrequency ablation (RFA) is a potentially curative therapy for nontransplantable hepatocellular carcinoma (HCC). However, as tumor size increases, incomplete RFA can increase rates of local recurrence and tumor progression. As such, there remains a need to identify potential biologic mechanisms mediating HCC response to thermal ablation. Our results revealed that miR-103 was markedly upregulated in recurrent HCC tissues treated with RFA as first-line treatment and in HCC lines after heat stress in vitro, simulating the marginal zone of RFA treatment. Gain-of-function and loss-of-function studies showed that miR-103 ectopic overexpression promoted, but miR-103 silencing reduced, heat-exposed HCC proliferation, and migration in vitro. Western blotting displayed that proteins related with proliferation and migration were significantly changed in different groups. Furthermore, PTEN may be a potential target of miR-103 and miR-103 could activate the PI3K/Akt pathway by suppressing PTEN expression. Taken together, these studies provide experimental evidence supporting a role for miR-103 in HCC response to heat stress. IJCEP
Copyright © 2020.

Entities:  

Keywords:  Hepatocellular carcinoma; PI3K/AKT signaling; miR-103; migration; proliferation; radiofrequency ablation

Year:  2020        PMID: 32269684      PMCID: PMC7137015     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

Review 1.  Local-regional treatment of hepatocellular carcinoma.

Authors:  Riccardo Lencioni; Laura Crocetti
Journal:  Radiology       Date:  2012-01       Impact factor: 11.105

2.  miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.

Authors:  Hsin-Yi Chen; Yu-Min Lin; Hsiang-Ching Chung; Yaw-Dong Lang; Ching-Jung Lin; John Huang; Wei-Chi Wang; Feng-Mao Lin; Zhen Chen; Hsien-Da Huang; John Y-J Shyy; Jin-Tung Liang; Ruey-Hwa Chen
Journal:  Cancer Res       Date:  2012-05-16       Impact factor: 12.701

3.  PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.

Authors:  Jana Samarin; Vibor Laketa; Mona Malz; Stephanie Roessler; Ilan Stein; Elad Horwitz; Stephan Singer; Eleni Dimou; Antonio Cigliano; Michaela Bissinger; Christine Susanne Falk; Xin Chen; Steven Dooley; Eli Pikarsky; Diego Francesco Calvisi; Carsten Schultz; Peter Schirmacher; Kai Breuhahn
Journal:  Hepatology       Date:  2016-01-14       Impact factor: 17.425

4.  miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.

Authors:  Kai Liu; Songyang Liu; Wei Zhang; Baoxing Jia; Ludong Tan; Zhe Jin; Yahui Liu
Journal:  Oncol Rep       Date:  2015-06-04       Impact factor: 3.906

5.  Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study.

Authors:  Scott M Thompson; Matthew R Callstrom; Kim A Butters; Shari L Sutor; Bruce Knudsen; Joseph P Grande; Lewis R Roberts; David A Woodrum
Journal:  Cardiovasc Intervent Radiol       Date:  2014-01-23       Impact factor: 2.740

Review 6.  Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma.

Authors:  L Tiong; G J Maddern
Journal:  Br J Surg       Date:  2011-07-15       Impact factor: 6.939

7.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

8.  Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer.

Authors:  Ryoji Nonaka; Yuichiro Miyake; Taishi Hata; Yoshinori Kagawa; Takeshi Kato; Hideki Osawa; Junichi Nishimura; Masakazu Ikenaga; Kohei Murata; Mamoru Uemura; Daisuke Okuzaki; Ichiro Takemasa; Tsunekazu Mizushima; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Int J Oncol       Date:  2015-06-26       Impact factor: 5.650

9.  MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.

Authors:  Wei Xia; Jing Ni; Juhua Zhuang; Leixing Qian; Peng Wang; Jiening Wang
Journal:  Int J Biochem Cell Biol       Date:  2015-12-02       Impact factor: 5.085

10.  TFF1 activates p53 through down-regulation of miR-504 in gastric cancer.

Authors:  Mohammed Soutto; Zheng Chen; Mohamed A Saleh; Ahmed Katsha; Shoumin Zhu; Alexander Zaika; Abbes Belkhiri; Wael El-Rifai
Journal:  Oncotarget       Date:  2014-07-30
View more
  3 in total

Review 1.  Regulators at Every Step-How microRNAs Drive Tumor Cell Invasiveness and Metastasis.

Authors:  Tomasz M Grzywa; Klaudia Klicka; Paweł K Włodarski
Journal:  Cancers (Basel)       Date:  2020-12-10       Impact factor: 6.639

2.  MiR-103a promotes tumour growth and influences glucose metabolism in hepatocellular carcinoma.

Authors:  Yuling Liu; Yuanzhou Zhang; Bowen Xiao; Ning Tang; Jingying Hu; Shunshun Liang; Yechun Pang; Huili Xu; Junping Ao; Juan Yang; Xiaofei Liang; Lin Wei; Yunfeng Wang; Xiaoying Luo
Journal:  Cell Death Dis       Date:  2021-06-15       Impact factor: 8.469

3.  A new clinical prognostic nomogram for liver cancer based on immune score.

Authors:  Qinyan Shen; Guinv Hu; JinZhong Wu; Liting Lv
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.